Diabetes drug Avandia gets new setback ahead of US decision
by admin on 10/07/10 at 2:44 pm
GlaxoSmithKline’s blockbuster diabetes treatment Avandia suffered a new setback Friday when US health officials offered more evidence of the drug’s increased link to heart problems.
